Characteristics of Interpolyelectrolyte Complexes Based on Different Types of Pectin with Eudragit® EPO as Novel Carriers for Colon-Specific Drug Delivery

被引:2
|
作者
Nasibullin, Shamil F. [1 ]
Dunaeva, Julia V. [1 ]
Akramova, Lilija A. [1 ]
Timergalieva, Venera R. [1 ]
Moustafine, Rouslan I. [1 ]
Skorik, Yury A.
Popa, Marcel
机构
[1] Kazan State Med Univ, Inst Pharm, 16 Fatykh Amirkhan St, Kazan 420126, Russia
基金
俄罗斯科学基金会;
关键词
Eudragit (R) EPO; citrus pectin; apple pectin; diclofenac sodium; interpolyelectrolyte complex; CONTROLLED-RELEASE; POLYELECTROLYTE COMPLEXES; POTENTIAL CARRIERS; SODIUM ALGINATE; MIXED FILMS; E PO; CHITOSAN; SYSTEMS; DESIGN; COPOLYMERS;
D O I
10.3390/ijms242417622
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Given that pectin is a well-known substance used for drug delivery, we aimed to obtain and further examine the efficacy of interpolyelectrolyte complexes based on citrus or apple pectin and the Eudragit (R) EPO for using these carriers in oral drug delivery. To characterize the physicochemical properties of these compounds, turbidity, gravimetry, viscosity, elementary analysis, FTIR spectroscopy, and DSC analysis were utilized. Diffusion transport characteristics were evaluated to assess the swelling ability of the matrices and the release of diclofenac sodium. To examine the release parameters, mathematical modeling was performed by using the Korsmayer-Peppas and Logistic equations as well. During the turbidity study, stoichiometry compositions were selected for the developed IPECs EPO/PecA and EPO/PecC at pH values = 4.0, 5.0, 6.0, and 7.0. The FTIR spectra of the complexes were characterized by an increase in the intensity of the bands at 1610 cm-1 and 1400 cm-1. According to the DSC analysis, IPEC has a certain Tg = 57.3 degrees C. The highest release rates were obtained for IPEC EPO/PecC_1 and EPO/PecC_4. The mechanism of drug transport from the matrices IPEC EPO/PecC, IPEC EPO/PecA_3, and EPO/PecA_4 can be characterized as Super Case II. Anomalous release (non-Fickian release) is typical for IPEC EPO/PecA_1 and EPO/PecA_2. Thus, the resulting systems can be further used for the effective delivery of the drugs to the colon.
引用
收藏
页数:19
相关论文
共 50 条
  • [41] Comparative evaluation of interpolyelectrolyte complexes of chitosan with Eudragit® L100 and Eudragit® L100-55 as potential carriers for oral controlled drug delivery
    Moustafine, Rouslan I.
    Margulis, Evgeniya B.
    Sibgatullina, Liliya F.
    Kemenova, Vera A.
    Van den Mooter, Guy
    EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2008, 70 (01) : 215 - 225
  • [42] Formulation and optimisation of lamivudine-loaded Eudragit(R) S 100 polymer-coated pectin microspheres for colon-specific delivery
    Vilas, Satheesh
    Thilagar, Sivasudha
    IET NANOBIOTECHNOLOGY, 2021, 15 (01) : 90 - 99
  • [43] Design and evaluation of colon-specific drug delivery system based on cyclodextrin conjugates
    Hirayama, F
    Minami, K
    Uekama, K
    PROCEEDINGS OF THE 9TH INTERNATIONAL SYMPOSIUM ON CYCLODEXTRINS, 1999, : 247 - 250
  • [44] A New Natural Angelica Polysaccharide Based Colon-Specific Drug Delivery System
    Zhou, Siyuan
    Zhang, Bangle
    Liu, Xinyou
    Teng, Zenghui
    Huan, Menglei
    Yang, Tiehong
    Yang, Zhifu
    Jia, Min
    Mei, Qibing
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2009, 98 (12) : 4756 - 4768
  • [45] Development and characteristics nanoscale retrograded starch as an encapsulating agent for colon-specific drug delivery
    Ding, Yongbo
    Lin, Qinlu
    Kan, Jianquan
    COLLOIDS AND SURFACES B-BIOINTERFACES, 2018, 171 : 656 - 667
  • [46] Designing colon-specific delivery systems for anticancer drug-loaded nanoparticles: An evaluation of alginate carriers
    Ma, Yiming
    Coombes, Allan G. A.
    JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A, 2014, 102 (09) : 3167 - 3176
  • [47] Novel oral colon-specific drug delivery systems for pharmacotherapy of peptide and nonpeptide drugs
    Reddy, SM
    Sinha, VR
    Reddy, DS
    DRUGS OF TODAY, 1999, 35 (07) : 537 - 580
  • [48] Amino acid derivatives of UDCA as novel prodrugs for colon-specific drug delivery.
    Clerici, C
    Pellicciari, R
    Setchell, K
    O'Connel, N
    Gentili, G
    Morelli, O
    Clementi, M
    Russo, G
    Marinozzi, G
    Gallo, P
    Verta, M
    Morelli, A
    GASTROENTEROLOGY, 2000, 118 (04) : A517 - A517
  • [49] A COLON-SPECIFIC DRUG-DELIVERY SYSTEM BASED ON DRUG GLYCOSIDES AND THE GLYCOSIDASES OF COLONIC BACTERIA
    FRIEND, DR
    CHANG, GW
    JOURNAL OF MEDICINAL CHEMISTRY, 1984, 27 (03) : 261 - 266
  • [50] Facts, fallacies and future of dissolution testing of polysaccharide based colon-specific drug delivery
    Kotla, Niranjan Goud
    Gulati, Monica
    Singh, Sachin Kumar
    Shivapooja, Ashwini
    JOURNAL OF CONTROLLED RELEASE, 2014, 178 : 55 - 62